BioCentury
ARTICLE | Clinical News

Rezular averapamil gastrointestinal data

February 25, 2008 8:00 AM UTC

In an open-label, 3-way crossover, pharmacokinetic study in 16 volunteers, there were no detectable levels of the S-isomer after treatment with 80 mg Rezular arverapamil under fasting conditions. Unde...